MY10 is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the production of drugs targeting cardiovascular diseases, where its chemical structure contributes to the efficacy of the final medication. Additionally, MY10 is utilized in the development of anti-inflammatory and analgesic drugs, helping to reduce pain and inflammation in patients. Its application extends to the field of oncology, where it is incorporated into the synthesis of chemotherapeutic agents designed to combat specific types of cancer. The compound's versatility and stability make it a valuable component in the formulation of advanced therapeutic solutions.